Results 41 to 50 of about 71,955 (233)

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial

open access: yesJournal of Clinical Medicine, 2020
Hereditary hemorrhagic telangiectasia is a rare but ubiquitous genetic disease. Epistaxis is the most frequent and life-threatening manifestation and tacrolimus, an immunosuppressive agent, appears to be an interesting new treatment option because of its
S. Dupuis-Girod   +12 more
semanticscholar   +1 more source

Clinical Profile of Filipino Patients with Epistaxis in a University Hospital

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2019
Objective: To present the demographic profile, etiology and treatment outcome of patients presenting with epistaxis in our local setting. Methods:           Design: Retrospective Study           Setting: Tertiary Private University Hospital  
Therese Monique D.G. Gutierrez   +1 more
doaj   +1 more source

Differential effect of meteorological factors and particulate matter with ≤ 10-µm diameter on epistaxis in younger and older children

open access: yesScientific Reports, 2022
The differential effect of meteorological factors and air pollutants on pediatric epistaxis in younger and older children has not been evaluated. We evaluated the distribution of pediatric epistaxis cases between younger (0–5 years) and older children (6–
Il-Youp Kwak   +2 more
doaj   +1 more source

Winter peaks in web-based public inquiry into epistaxis

open access: yesEuropean Archives of Oto-Rhino-Laryngology, 2020
Purpose Epistaxis represents the most frequent ear, nose, throat-related emergency symptom. Seasonal variation in epistaxis incidence, with peaks during winter months, is widely accepted, although the literature itself remains inconclusive. The objective
D. Liu   +4 more
semanticscholar   +1 more source

Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia [PDF]

open access: yes, 2015
Hereditary hemorrhagic telangiectasia (HHT) is mechanistically and therapeutically challenging, not only because of the molecular and cellular perturbations that generate vascular abnormalities, but also the modifications to circulatory physiology that ...
Shovlin, CL
core   +2 more sources

Environmental factors differentially affect epistaxis among preschool and school-aged children

open access: yesFrontiers in Public Health, 2023
IntroductionEnvironmental factors are closely associated with pediatric epistaxis. Whether this association differs according to age has not been previously reported.
Eun-Jin Ahn, Hyun Jin Min, Hyun Jin Min
doaj   +1 more source

Current Approaches to Epistaxis Treatment in Primary and Secondary Care.

open access: yesDeutsches Ärzteblatt International, 2018
BACKGROUND The lifetime prevalence of epistaxis is approximately 60%, and 6-10% of the affected persons need medical care. In rare cases, severe bleeding calls for the rapid initiation of effective treatment.
R. Beck   +3 more
semanticscholar   +1 more source

A systematic review of the probability of asphyxia in children aged <2 years with unexplained epistaxis [PDF]

open access: yes, 2016
ObjectiveTo determine the proportion of children aged
Carter, Ben   +3 more
core   +2 more sources

Endoscopic Cauterization of Sphenopalatine Artery in Posterior Epistaxis- Our Experience

open access: yesBengal Journal of Otolaryngology and Head Neck Surgery, 2015
Introduction Epistaxis is one of the commonest emergencies in Otorhinolaryngology. The management of intractable posterior epistaxis sometime becomes challenging to ENT surgeons.
Mukesh Kumar Singh   +4 more
doaj   +3 more sources

Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy

open access: yesEndoscopy International Open, 2018
Background and study aims Unsedated transnasal endoscopy (uTNE) has become accepted as a safe and tolerable method for upper gastrointestinal tact examinations.
Yoshiya Kobayashi   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy